Enochian Biosciences Inc. (ENOB) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear

Enochian Biosciences Inc.

NASDAQ: ENOB · Real-Time Price · USD
0.71
0.01 (1.43%)
At close: Aug 04, 2023, 9:58 PM

Enochian Biosciences Cash Flow Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Jun 30, 2025 Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
Net Income
-178.01M -80.65M -39,684.1B -113.43M -26.72M
Depreciation & Amortization
129.09K 121.86K 113.5B 123.59K 391.42K
Stock-Based Compensation
3.31M 4.67M 3,535.1B 5.49M 1.44M
Other Working Capital
n/a n/a n/a 333.8K 1.2M
Other Non-Cash Items
166.69M 64.88M 24,261B 90.67M 3.34M
Deferred Income Tax
n/a n/a -3,895B n/a n/a
Change in Working Capital
n/a n/a 3,895B 1.42M 932.13K
Operating Cash Flow
-7.87M -10.97M -11,774.5B -15.73M -20.61M
Capital Expenditures
n/a -70.43K -29.77B -5.16K -48.89K
Cash Acquisitions
n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a
Other Investing Acitivies
-500K -1.19M n/a n/a n/a
Investing Cash Flow
-500K -1.26M -29.77B -5.16K -48.89K
Debt Repayment
n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a
Other Financial Acitivies
8.38M 10.52M 4,515.1B 4.25M 32.6M
Financial Cash Flow
8.38M 10.52M 4,515.1B 4.25M 32.6M
Net Cash Flow
-127.77K -1.65M -7,297.7B -11.49M 11.97M
Free Cash Flow
-7.87M -11.04M -11,804.3B -15.74M -20.66M